Welcome to this module on Anticoagulation in Primary Care. The purpose of the module is to support General Practitioners in prescribing appropriate anticoagulation. Access to this module is restricted to qualified General Practitioners and the website requires registration and an enrolment key which is provided by the ICGP. If you are a member of the public who has a query about warfarin or another anticoagulant, please contact your GP. Information is also available at the link below. 

Medicines Information

Module Overview

External CPD Credits: 3
GMS Study Leave: 1/2 day
No of Lessons: 4
MCQ Assessment
Certificate of Completion


Welcome to this module on Anticoagulation in Primary Care. The purpose of the module is to support General Practitioners in prescribing appropriate anticoagulation. Content addresses both Warfarin and Novel Oral Anticoagulants (NOACs). The module is based on the ICGP Quality in Practice (QIP) guidelines 'Anticoagulation in General Practice/ Primary Care, 2014 - Part 1: Warfarin & Part 2: New/novel oral anticoagulants'.
Overview of Module
This eLearning module is divided into 4 key lessons. Each lesson comprises a video presentation conveying the core material.  Most presentations are close to 10 minutes long to facilitate opportunistic learning. Supplementary lessons, where non-core material is presented, and relevant printable and downloadable material are also included within most lessons.

This Module was supported by an unrestricted educational grant from Pfizer Ireland :

pfizer Logo
        The 4 lessons are as follows:
        Lesson 1: Initiating Warfarin Therapy
        The Medicines Management Programme (MMP) in Ireland recommends warfarin as 'the agent of choice and the first-line anticoagulant, for most patients with atrial fibrillation', and it is increasingly prescribed and monitored in general practice. This lesson outlines current guidance around assessment prior to initiation of warfarin therapy.
        Lesson 2: Ongoing Monitoring & Management of Warfarin Therapy
        This lesson focuses on initiation & management of Warfarin therapy, and particularly on monitoring target INR (International Normalized Ratio) and TTR (time in therapeutic range). 
        Lesson 3: About Novel Oral Anticoagulants (NOACs)
        The arrival on the market of 3 new or novel oral anticoagulants or NOACs, expanded the pharmacological options for conditions needing anticoagulation. This lesson discusses the risk-benefit of NOACs versus warfarin. 
        Lesson 4: Prescribing & Monitoring Novel Oral Anticoagulants (NOACs)
        This lesson outlines issues and assessments which should be discussed & undertaken in all patients, both prior to commencement of a NOAC, and during follow-up. 


The Medical Council has defined eight domains of good professional practice. These domains describe a framework of competencies applicable to all doctors across the continuum of professional development from formal medical education and training through to maintenance of professional competence. Since they describe the outcomes which doctors should strive to achieve, doctors should refer to these domains throughout the process of maintaining competence. In order to assist you in planning your professional competence, ICGP eLearning highlight the domains addressed in each module as set out below. 
NOTE: While a number of ICGP modules have a tight focus on one or two domains, most modules endeavour to address all domains to some degree (low, medium, high). This is clearly displayed in the diagram below
Anticoagulation Domains

This site is being hosted by CPD Sessions Limited. Log in is restricted to those who have a valid ID and PIN issued from the Irish College of General Practitioners (ICGP).

Technical problems and registration issues will be addressed by contacting

For content-related queries, please contact

ICGP Contact Details:

Administrator:   Yvette Dalton

For members of the public wishing to learn about Anticoagulants we suggest you talk with your local GP or visit  

Last modified: Thursday, 3 November 2016, 2:45 PM